BIRADS 0 patient reclassification in a first-level of care unit

Authors

  • Graciela Garza-Rugerio <p>Instituto Mexicano del Seguro Social, Hospital General de Zona con Unidad de Medicina Familiar No. 2, Servicio de Medicina Familiar. Apizaco, Tlaxcala, M&eacute;xico.</p> http://orcid.org/0009-0006-2886-0012
  • Noe Muñoz-Ahuatzin <p>Instituto Mexicano del Seguro Social, Hospital General de Zona con Unidad de Medicina Familiar No. 2, Servicio de Medicina Familiar. Apizaco, Tlaxcala, M&eacute;xico.</p> http://orcid.org/0009-0002-4667-7415
  • Maria de la Luz León-Vázquez <p>Instituto Mexicano del Seguro Social, &Oacute;rgano de Operaci&oacute;n Administrativa Desconcentrada Tlaxcala, Coordinaci&oacute;n de Investigaci&oacute;n en Salud, Tlaxcala,&nbsp; Tlaxcala, M&eacute;xico.</p> http://orcid.org/0000-0002-5192-9704
  • Paola Maycotte-González <p>Instituto Mexicano del Seguro Social, &Oacute;rgano de Operaci&oacute;n Administrativa Desconcentrada Puebla, Centro de Investigaci&oacute;n Biom&eacute;dica de Oriente.&nbsp;Metepec, Puebla, M&eacute;xico</p> http://orcid.org/0000-0003-4059-0554
  • Patricia Seefoó-Jarquín <p>Instituto Mexicano del Seguro Social, Hospital General de Subzona con Unidad de Medicina Familiar No. 8, Coordinaci&oacute;n Cl&iacute;nica de Educaci&oacute;n e Investigaci&oacute;n en Salud. Tlaxcala, Tlaxcala, M&eacute;xico.</p> http://orcid.org/0000-0002-7558-2303

DOI:

https://doi.org/10.5281/

Keywords:

Breast Neoplasms, Early Detection of Cancer, Ultrasonography, Mammary, Diagnostic Imaging, Radiography

Abstract

Background: In Mexico and the world, breast cancer is the cancer type with the highest incidence and mortality for women. Its incidence has increased due to a higher life expectancy and a higher exposure to risk factors. Screening is done by mammography using the BIRADS (Breast Imaging Reporting and Data System) system, the standard for mammography screening report which classifies lesions assigning recommendations for patient follow-up. The system goes from 0 (not conclusive) to 6 (demonstrated malignancy), being of interest for this study the BIRADS 0 category.

Objective: To describe patients classified as BIRADS 0 by mammography and their reclassification in a first-level hospital during 2021.

Material and methods: Retrospective, descriptive, cross-sectional, observational study. Women over 40 years with a BIRADS 0 result were studied. The following databases were used: Institutional Cancer Registry, Family Medicine Information System, Electronic Clinical File, and the mammography and patient list from preventive medicine.

Results: Reclassification by ultrasound (US) was achieved in 100% of patients, in all of the BIRADS US categories. In 3.8% of BIRADS 0 patients, ductal adenocarcinoma was found and confirmed by histological testing.

Conclusion: All of the reassessed lesions with US were adequately reclassified.

Downloads

Download data is not yet available.

References

Arnold M, Morgan E, Rumgay H, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 2022;66:15-23. doi: 10.1016/j.breast.2022.08.010

Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. The British Journal of Radiology. 2022;95(1130):20211033. doi: 10.1259/bjr.20211033

Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-249. doi: 10.3322/caac.21660

Cárdenas-Sánchez J. Consenso mexicano sobre diagnóstico y tratamiento del cáncer mamario. Gac Mex Oncol. 2021;20(Suppl 2):100-5. Disponible en: http://consensocancermamario.com/documentos/RevistaGamo2021.pdf

Kashyap D, Pal D, Sharma R, et al. Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures. Biomed Res Int. 2022;2022:9605439. doi: 10.1155/2022/9605439

Ren W, Chen M, Qiao Y, et al. Global guidelines for breast cancer screening: A systematic review. Breast. 2022;64:85-99. doi: 10.1016/j.breast.2022.04.003

Newman LA. Breast cancer screening in low and middle-income countries. Best Pract Res Clin Obstet Gynaecol. 2022;83:15-23. doi: 10.1016/j.bpobgyn.2022.03.018

Duffy S, Vulkan D, Cuckle H, et al. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT. Health Technol Assess. 2020;24(55):1-24. doi: 10.3310/hta24550

Mann RM, Hooley R, Barr RG, et al. Novel Approaches to Screening for Breast Cancer. Radiology. 2020;297(2):266-85. doi: 10.1148/radiol.2020200172

Feldman ED, Oppong BA, Willey SC. Breast cancer screening: clinical, radiologic, and biochemical. Clin Obstet Gynecol. 2012;55(3):662-70. doi: 10.1097/GRF.0b013e31825ca884

Edmonds CE, O'Brien SR, Conant EF. Mammographic Breast Density: Current Assessment Methods, Clinical Implications, and Future Directions. emin Ultrasound CT MR. 2023;44(1):35-45. doi: 10.1053/j.sult.2022.11.001.

Bodewes FTH, van Asselt AA, Dorrius MD, et al. Mammographic breast density and the risk of breast cancer: A systematic review and meta-analysis. Breast. 2022;66:62-8. doi: 10.1016/j.breast.2022.09.007

Tadesse GF, Tegaw EM, Abdisa EK. Diagnostic performance of mammography and ultrasound in breast cancer: a systematic review and meta-analysis. J Ultrasound. 2023;26(2):355-367. doi: 10.1007/s40477-022-00755-3

Camacho-Piedra C, Espíndola-Zarazúa V. Actualización de la nomenclatura BI-RADS por mastografía y ultrasonido. Anales de Radiología México. 2018;17:100-8. doi: 10.24875/ARM.M18000015

Flemban AF. Overdiagnosis Due to Screening Mammography for Breast Cancer among Women Aged 40 Years and Over: A Systematic Review and Meta-Analysis. J Pers Med. 2023;13(3):523. doi: 10.3390/jpm13030523

Pesce K, Orruma MB, Hadad C, et al. BI-RADS Terminology for Mammography Reports: What Residents Need to Know. Radiographics. 2019;39(2):319-20. doi: 10.1148/rg.2019180068

Magny SJ, Shikhman R, Keppke AL. Breast Imaging Reporting and Data System. StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.

Orel SG, Kay N, Reynolds C, et al. BI-RADS Categorization As a Predictor of Malignancy. Radiology. 1999;211(3):845-50. doi: 10.1148/radiology.211.3.r99jn31845

Mendelson EB, Böhm-Vélez M, Berg WA, et al. E. ACR BI-RADS® Ultrasound. Reston, VA: American College of Radiology; 2013.

Norma Oficial Mexicana NOM-041-SSA2-2011, para la prevención, diagnóstico, tratamiento, control y vigilancia epidemiológica del cáncer de mama. México: Secretaría de Salud; 2011.

Guía de Práctica Clínica, Prevención, Tamizaje y Referencia Oportuna de Casos Sospechosos de Cáncer de Mama en el Primer Nivel de Atención. Ciudad de México, México: Centro Nacional de Excelencia Tecnológica en Salud, Secretaría de Salud; 2017.

Melnikow J, Fenton JJ, Whitlock EP, et al. Supplemental Screening for Breast Cancer in Women with Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force. Ann Intern Med. 2016;164(4):268-78. doi: 10.7326/M15-1789

Pishdad P, Moosavi A, Jalli R, et al. How can additional ultrasonography screening improve the detection of occult breast cancer in women with dense breasts? Pol J Radiol. 2020;85:e353-60. doi: 10.5114/pjr.2020.97944

Knerr S, Wernli KJ, Leppig K, et al. A web-based personalized risk communication and decision-making tool for women with dense breasts: Design and methods of a randomized controlled trial within an integrated health care system. Contemp Clin Trials. 2017;56:25-33. doi: 10.1016/j.cct.2017.02.009

Aguilar Angulo PM, Romero-Castellano C, Sanchez-Casado M, et al. BI-RADS classification in breast tomosynthesis. Our experience in breast cancer cases categorized as BI-RADS 0 in digital mammography. EPOS. 2017. doi: 10.1594/ecr2017/C-0562

Chou HH, Chen SC. Clinical Analysis of the Outcome of Breast Ultrasound after Screening Mammography as Breast Imaging Reporting and Data System (Bi-Rads) Category 0. Ultrasound in Medicine and Biology. 2017;43(Supp 1):OPT2-015. doi: 10.1016/j.ultrasmedbio.2017.08.1013

Maxim C. Diagnostic value of MRI optimized protocols in evaluation of BI-RADS category 0 lesions detected by conventional imaging. The Moldovan Medical Journal. 2018;61.

Waheed H, Masroor I, Afzal S, et al. Digital Breast Tomosynthesis Versus Additional Diagnostic Mammographic Views for the Evaluation of Asymmetric Mammographic Densities. Cureus. 2020;12(8):e9637. doi: 10.7759/cureus.9637

Lawson MB, Oluyemi ET. Reducing Disparities in Timely Follow-Up After Abnormal Findings on Screening Mammography. Journal of the American College of Radiology. 2022;19(11):1269-70. doi: 10.1016/j.jacr.2022.08.003

Wang YC, Lin CH, Huang SP, et al. Risk Factors for Female Breast Cancer: A Population Cohort Study. Cancers. 2022;14(3). doi: 10.3390/cancers14030788

Wolin KY, Colangelo LA, Chiu BC, et al. Associations of physical activity, sedentary time, and insulin with percent breast density in Hispanic women. J Womens Health (Larchmt). 2007;16(7):1004-11. doi: 10.1089/jwh.2006.0282

Ochi T, Tsunoda H, Yamauchi H, et al. Impact of childbirth history on dense breast in mammographic screening: a cross-sectional study. BMC Womens Health. 2022;22(1):194. doi: 10.1186/s12905-022-01772-4

Pepłońska B, Kalużny P. Cigarette smoking and mammographic breast density among Polish women. Int J Occup Med Environ Health. 2021;34(6):805-15. doi: 10.13075/ijomeh.1896.01832.

Downloads

Published

2023-12-21

Issue

Vol. 62 No. 1 (2024): January-February

Section

Original Articles

License

Copyright (c) 2023 Revista Médica del Instituto Mexicano del Seguro Social

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.